跳至主要内容
临床试验/NL-OMON53590
NL-OMON53590招募中不适用

sability of Levodopa Cyclops* compared to INBRIJA® during an off episode in Parkinson*s disease patients - Usability of Levodopa Cyclops* vs INBRIJA® in Parkinson*s patients

Martini Ziekenhuis0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Diagnosed with Parkinson*s disease by a neurologist;
  • - At least 18 years of age;
  • - Regularly suffering from predictable off episodes despite PD medication;
  • - Recognizable off episodes for themselves and others;
  • - Signed informed consent.

排除标准

  • - Not able to understand an inhalation instruction of either the Levodopa
  • Cyclops* or the INBRIJA® (within a maximum of 20 minutes of explanation per
  • - Cognitive dysfunction, which precludes good understanding of instructions
  • and/or informed consent;
  • - Previously participated in the Parkinson DPI-1, DPI-2, DPI-3, DPI-4 or DPI-5
  • study (prior knowledge of the inhalation maneuver of the Levodopa Cyclops*)
  • - Having experience with using the INBRIJA® inhaler.

研究者

相似试验

sability of Levodopa Cyclops* compared to INBRIJA®... | 临床试验